INTRODUCTION
Non-gonococcal urethritis (NGU) appears to be the most frequent sexually transmitted disease in industrialized countries [1, 2, 3] . Approximately 50 percent of NGU cases are caused by Chlamydia trachomatis (3] . In addition, it has been well established that Ureaplasma urealyticum is another etiologic agent of NGU [3, 4] . But, in an individual man with chlamydia-negative urethritis, it has been difficult to demonstrate that U. urealyticum is the causative pathogen, because up to 70 percent of healthy persons harbor the organisms in their urethra [3, 4, 5] . Titer rises of serum antibodies in NGU patients have not been demonstrated so far, either because of the insufficient sensitivity of the methods employed or because of the superficial nature of the infection, which does not induce high levels of systemic antibodies. In a different approach, we have therefore used quantitative procedures to establish the possibility of U. urealyticum as the etiologic agent in individual patients with NGU and thus determine the role of the organisms as a primary pathogen in this disease.
The etiology of chronic prostatitis is by far more obscure than that of NGU [6] . Common pathogens of the urogenital tract can only be found with low frequency (< 10 percent) in patients with chronic prostatitis. Because U. urealyticum can cause urethritis, the possibility arises that the organisms also induce ascending inflammatory reactions of the prostate. Since the technique of Meares and Stamey has suc-545 cessfully been used to localize infections of the male genital tract with common bacteria, we have employed this procedure, together with quantitative culture techniques, for common bacteria, candida species, U. urealyticum, and Mycoplasma hominis in order to unravel the role of the latter two species in chronic prostatitis [7] . This publication summarizes data on 164 patients with NGU and 597 men with chronic prostatitis [8, 9] .
STUDY POPULATION AND METHODS Study Population
One hundred and sixty-four patients (mean age, 34 years), attending the outpatient clinic of the Department of Urology, University of Giessen, from January 1, 1979, until December 31, 1980, were studied. All men complained of spontaneous urethral discharge. The presence of Neisseria gonorrhoeae was excluded by gram stain and inoculation of discharge on Thayer-Martin agar.
In (Table 1) In men with NGU, 0.01 ml of urethral discharge was taken with a bacteriological loop from the meatus urethrae and transferred to a transport medium [10] . In addition, fluor urethrae was inoculated into cycloheximide-treated McCoy cells for the cultivation of chlamydiae [11] . For isolation of ureaplasmas and mycoplasmas, 0.1 ml of the transport medium and 0.1 ml of first-voided urine were inoculated on A-6D agar, later A-7 agar, and into U-9 broth [12, 13] . For cultivation of M. hominis a standard mycoplasma agar and broth were also inoculated. These two media were later omitted, when it was found that M. hominis could be isolated with the same efficiency on A-6-D, resp. A-7, agar and U-9 broth. After incubation of agar plates for five days under anaerobic conditions (Gas-Pak-System, Becton-Dickinson, Heidelberg, FRG) colonies were counted, using a dissecting microscope at a magnification of 25 x. The U-9 broth was observed twice daily for a color change of the pH indicator. When the indicator started to change color, subcultivation was performed immediately on agar plates. If a color change was not seen after five days, the tubes were discarded. Ureaplasmas were identified by their characteristic colony morphology and by their resistance to lincomycin. M. hominis was identified by epi-immunofluorescence. Details of the procedures have been described previously [8] [9] [10] . 
RESULTS

Non-Gonococcal Urethritis
As can be seen in Table 2 , U. urealyticum could be isolated in numbers of more than 104 colony-forming units (CFU) from urethral discharge and more than 103 CFU per ml from VB% in 48 (29.3 percent) of the 164 NGU patients. In six of these 48 patients, mixed infections with M. hominis, also in high numbers, were observed. In 18 patients (11 percent) U. urealyticum in high numbers and C. trachomatis were isolated, whereas C. trachomatis alone was seen in 59 (36 percent) of men with NGU. Ten or more leucocytes per high-power field (400 x) of the sediment from VBy were observed in 71.7 percent of chlamydia-positive, ureaplasma-negative men and 47.6 percent of the 42 patients with high ureaplasma numbers. Furthermore, T. Meares and Stamey [7] , was observed for U. urealyticum (Table 3) . Eighty of these patients had high numbers of ureaplasmas in EPS and 51 also in VB3 but low numbers or no ureaplasmas in VB1 and VB2. In the remaining two patients, who had high ureaplasma numbers in VB1 and VB2, CFU in dance with a prostatitis histogram. In an additional nine patients, high numbers of ureaplasmas were observed in VB1, VB2 (eight patients), and EPS (data not shown).
In these men a significant difference in the number of organisms between VB, resp. VB2 and EPS was not seen, indicating most probably prostato-urethritis. If these nine are added to the previous group of 82 men, a total of 91 (15.2 percent) of the patients may be considered to suffer from ureaplasma-associated chronic prostatitis. The 82 men with ureaplasma-associated prostatitis were treated with 500 mg of tetracycline-HCl twice daily for 14 days. Seventy-one of these patients were cured 21
to 28 days after start of treatment, and ureaplasmas were no longer detected. Seven of the remaining eleven men had bladder neck obstruction. In four men no obvious explanation for the therapy failure could be found. M. hominis was cultured from ten men in the typical prostatitis configuration, but always in mixed infections with high numbers of either U. urealyticum (seven men), Escherichia coli (two), or Streptococcus faecalis (one), who also showed a prostatitis pattern (Table 3 ). In an additional 12 patients, from whom M. hominis could be isolated in high numbers, a prostatitis histogram was not seen (data not shown).
Eleven of these men had more than 103 CFU in VB1, midstream-urine, and EPS.
U. urealyticum was isolated from VB1 (eight men), VB2 (none), EPS (three men), and VB3 (three men) of the 48 healthy persons but always in numbers below 103 CFU per ml. M. hominis was cultured from VB1 (six men), VB2 (none), EPS (one man), and VB3 (one man) of healthy volunteers. Although in one man more than 104 CFU of M. hominis per ml ofEPS and 103.' CFU per ml of VB3 were isolated, he did not exhibit any symptoms or signs of lower genital tract disease.
In 32 (5.4 percent) of the 597 men, common urinary tract pathogens caused the disease, whereas 187 (31.3 percent) patients suffered from prostatodynia. In the remaining patients variable results were obtained which did not permit an etiological diagnosis.
DISCUSSION
Our studies on non-gonococcal urethritis have confirmed previous findings, which indicated that approximately 45 to 50 percent of the NGU cases are caused by C. trachomatis [1, 2, 3] . In addition, evidence was provided that in approximately 30 percent of the NGU patients U. urealyticum was the etiologic agent. As expected, in 11 percent of patients a mixed infection of C. trachomatis and high numbers of U. urealyticum was observed. In these men the etiology remained obscure.
In previous studies on 312 patients with prostato-urethritis, it was demonstrated that disease symptoms in men, who had high numbers of U. urealyticum inEPS and VB3, disappeared after tetracycline treatment, and the mycoplasmas could not be reisolated, whereas in patients with high numbers of M. hominis disease symptoms persisted, although mycoplasmas were no longer detected after therapy [14] . The data indicated that U. urealyticum, but not M. hominis, was connected with disease. In further studies, tetracycline therapy was therefore considered to be justified only in patients with high numbers of U. urealyticum.
Ureaplasma-associated prostatitis was evident in 13.7 to 15.2 percent of men with chronic prostatitis. Therapy failure in 11 of these patients could be explained by bladder neck obstruction, reinfection via the sexual partner, or by appearance of tetracycline-resistant ureaplasmas [15] . In addition, infection with another tetracycline-sensitive microorganism should be considered [161. The data do not ultimately prove the etiologic importance of U. urealyticum in these men, but isola-tion and treatment results point in this direction. Further studies, using serum or local antibody determinations and/or serotyping of isolates could provide additional evidence for the causative role of the organisms in chronic prostatitis.
For the etiological diagnosis of NGU we regard it as mandatory to include culture procedures for C. trachomatis and quantitative (CFU) determinations of U. urealyticum. In chronic prostatitis, the localization technique of Meares and Stamey can now be recommended for the diagnosis of ureaplasma infection similar to its previous use for prostatitis caused by common bacteria.
